Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0599766 (
functional recovery
)
13,441
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In the adult brain,
vascular endothelial growth factor D
(
VEGFD
) is required for structural integrity of dendrites and cognitive abilities. Alterations of dendritic architectures are hallmarks of many neurologic disorders, including stroke-induced damage caused by toxic extrasynaptic NMDA receptor (eNMDAR) signaling. Here we show that stimulation of eNMDARs causes a rapid shutoff of
VEGFD
expression, leading to a dramatic loss of dendritic structures. Using the mouse middle cerebral artery occlusion (MCAO) stroke model, we have established the therapeutic potential of recombinant mouse
VEGFD
delivered intraventricularly to preserve dendritic architecture, reduce stroke-induced brain damage, and facilitate
functional recovery
. An easy-to-use therapeutic intervention for stroke was developed that uses a new class of
VEGFD
-derived peptide mimetics and postinjury nose-to-brain delivery.
...
PMID:Nasally delivered VEGFD mimetics mitigate stroke-induced dendrite loss and brain damage. 3222 71